Genzyme is owned by Sanofi US.

Sanofi is one of the...

Sanofi is a company listed under the stock ticker SAN (FR).

Sanofi has a direct presence in 42 countries.

Sanofi has 56 subsidiaries including Euroapi, Genzyme and Genzyme Australia & NZ.

They are in:


View its 35 main executives

Most searched biographies at Genzyme
Popular executive movements at Sanofi
  • Roy Papatheodorou will join the company as Executive Vice President, General Counsel and Head of Legal, Ethics & Business Integrity on Feb. 1, 2022  (posted on July 29 2021).
  • Brendan O'Callaghan who is Global Head of Biologics Platform & Industrial Affairs and Head of Specialty Care Portfolio, will be promoted to Executive Vice President and Global Head of Industrial Affairs on Oct. 1, 2021  (posted on July 29 2021).
  • Philippe Luscan, Member of the Executive Committee and Executive Vice President, Global Industrial Affairs, will retire in Oct. 2021  (posted on July 29 2021).

Create an alert
to follow the executive moves at Genzyme.


Sanofi has 2,047 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals
Popular contacts in Pharmaceuticals

Learn more about the Pharmaceuticals industry >

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.